Has Arica Hirsch, MD received payments from drug or device companies?

Yes. Drug and device makers reported $2,516 in general payments to Arica Hirsch, MD across 11 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Arica Hirsch, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Arica Hirsch, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Arica Hirsch, MD

Radiation Oncology · Park Ridge, ILNPI 1770574758

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $2,000 of the $2,516 with a category attached, or 79.5%. Davol Inc. accounts for 79.5% of it on its own, with 4 other manufacturers making up the rest. Reporting peaked in 2021 at $2,113 and has fallen 95.8% since, to $88 in 2024.

$2,516in general payments, 2019–2025

Across 11 payments — averaging $228.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Davol Inc.$2K
Accuray Incorporated$171
Elekta, Inc.$146
Reflexion Medical, Inc.$135
Boston Scientific$63

What the payments were for

Speaking & faculty fees$2,00079%
Food & beverage$51621%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Davol Inc.	1	$2,000
Accuray Incorporated	2	$171
Elekta, Inc.	2	$146
Reflexion Medical, Inc.	3	$135
Boston Scientific	3	$63

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

ELEKTA MEDICAL LINEAR ACCELERATOR$129

How this compares

$2,516 in reported general payments places this provider in the 80th percentile of 242 radiation oncology providers in Illinois.

See all radiation oncology providers in Illinois →

Medicare billing

Part B allowed, 2024

$173,554

Medicare patients

256

Services billed

1,561

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Tamsulosin Hcl	33	$356

Paid to pharmacies, not to this prescriber.

Other radiation oncology in Park Ridge

Ramji RajendranElk Grove Village$207K
Brian BaumannSpringfield$204K
Tamer RefaatFreeport$151K
Parthiv MehtaGlenview$149K
Sean PitrodaChicago$103K
Aditya JulooriChicago$73K
Steven ChmuraChicago$59K
Marc PosnerLake Forest$55K
William SmallChicago$54K
Ken TatebeChicago$42K

See the full list for Illinois →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →